The prevalence of HRD tumors amongst HGSOC that were related to BRCA1/2 deficiency (including BRCA1 promoter hypermethylation) was broadly in line with previous reports (Table S1) [17]. The gene discussed is BRCA1; the disease is hypoparathyroidism-retardation-dysmorphism syndrome.